Nalini Rajeshwara

Title: Nalini Rajeshwara: Innovator in Organ Toxicity Prediction

Introduction

Nalini Rajeshwara is a prominent inventor based in Bangalore, India. She has made significant contributions to the field of drug development through her innovative patent. Her work focuses on predicting organ toxicity, which is crucial for ensuring the safety and efficacy of new pharmaceuticals.

Latest Patents

Nalini holds a patent titled "Method for predicting organ toxicity and a system thereof." This patent describes a systems approach that utilizes mathematical modeling of essential biochemical pathways involved in organ homeostasis. By coupling this in silico model with in-vitro and/or in-vivo measurements, it allows for the quantification of drug-induced perturbations. This powerful platform enables accurate and mechanistic-level predictions of drug-induced organ injury. The method also demonstrates the capability to model various physiological situations beyond drug perturbations. Additionally, it can be integrated with high-throughput 'omics' data to generate testable hypotheses, facilitating informed decision-making in drug development. Nalini has 1 patent to her name.

Career Highlights

Nalini Rajeshwara is associated with Strand Life Sciences Pvt Ltd, where she applies her expertise in the field of biotechnology and pharmacology. Her innovative approach has positioned her as a key player in advancing drug safety assessments.

Collaborations

Some of her notable coworkers include Kalyanasundaram Subramanian and Sowmya Raghavan, who contribute to the collaborative efforts at Strand Life Sciences Pvt Ltd.

Conclusion

Nalini Rajeshwara's work in predicting organ toxicity represents a significant advancement in drug development. Her innovative methods and collaborative spirit continue to drive progress in ensuring safer pharmaceuticals.